HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil (Q43990086)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil |
scientific article |
Statements
1 reference
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil (English)
1 reference
Angelo Di Leo
1 reference
David Gancberg
1 reference
Denis Larsimont
1 reference
Minna Tanner
1 reference
Tero Jarvinen
1 reference
Ghizlane Rouas
1 reference
Stella Dolci
1 reference
Jean-Yves Leroy
1 reference
Marianne Paesmans
1 reference
Jorma Isola
1 reference
Martine J Piccart
1 reference
1 May 2002
1 reference
1 reference
8
1 reference
5
1 reference
1107-1116
1 reference
Identifiers
1 reference